Reuters logo
BRIEF-Neon Therapeutics To Collaborate with Merk on Clinical Trial
December 7, 2017 / 12:25 PM / 10 days ago

BRIEF-Neon Therapeutics To Collaborate with Merk on Clinical Trial

Dec 7 (Reuters) - Merck & Co Inc:

* NEON THERAPEUTICS ANNOUNCES CLINICAL TRIAL COLLABORATION WITH MERCK

* NEON THERAPEUTICS - ENTERED CLINICAL TRIAL COLLABORATION WITH MERCK TO EVALUATE CO‘S NEOANTIGEN VACCINE, NEO-PV-01, IN COMBINATION WITH MERCK‘S KEYTRUDA

* NEON THERAPEUTICS SAYS COLLABORATION AGREEMENT IS BETWEEN CO AND MERCK, THROUGH A SUBSIDIARY; ADDITIONAL DETAILS WERE NOT DISCLOSED.

* NEON THERAPEUTICS - CO, MERCK TO WORK ON PHASE 1B TRIAL EXAMINING SAFETY, PRELIMINARY EFFICACY OF NEO-PV-01 COMBINED WITH KEYTRUDA, AMONG OTHERS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below